Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn’s disease

Comparison of two dosing methods for ind

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: A randomized placebo-controlled trial

✍ Arie Levine; Michal Kori; Gabriel Dinari; Efrat Broide; Ron Shaoul; Baruch Yerus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 4 views

## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in